Literature DB >> 30222527

Comparison of Short-Term Outcomes Between 3D and 2D Imaging Laparoscopic Colectomy with D3 Lymphadenectomy for Colon Cancer.

Jin Yoon1, Sung Il Kang1, Min Hyun Kim1, Myung Jo Kim1, Heung-Kwon Oh1, Duck-Woo Kim1, Sung-Bum Kang1.   

Abstract

BACKGROUND: Three-dimensional (3D) imaging for laparoscopy was introduced to overcome the limitations of conventional two-dimensional (2D) imaging that lacked depth perception and spatial orientation. This study aimed to evaluate the effect of 3D imaging in laparoscopic colectomy with D3 lymphadenectomy for colon cancer.
METHODS: From February 2014 to October 2016, the prospective database of 278 consecutive patients with colon cancer was analyzed retrospectively; these patients underwent laparoscopic surgery with 2D (n = 111) and 3D (n = 167) imaging, with curative intent.
RESULTS: No difference was found in sex, body mass index, history of abdominal surgery, and American Society of Anesthesiologists grade between the 3D and 2D groups. The estimated blood loss was less in the 3D group than in the 2D group (50 mL [30-100 mL] versus 100 mL [50-100 mL], P < .001). The number of resected lymph nodes was higher in the 3D group (n = 47 [37.5-60] versus 41 [32-51.5], P = .001). However, a difference in operative time was not observed in both groups (150 minutes [125-175 minutes] versus 155 minutes [135-177.5 minutes], P = .186). Postoperative morbidity was similar in both groups (7.8% versus 8.1%, P = 1.000). Time to pass first flatus (3 days [2-4 days] versus 3 days [3-4 days], P = .746) and postoperative hospital stay (6 days [6-8 days] versus 6 days [6-7 days], P = .087) were also similar.
CONCLUSIONS: This study shows that laparoscopic colectomy with D3 lymphadenectomy for colon cancer using 3D laparoscopic systems appears to be beneficial, with less blood loss, which should be addressed in prospective studies.

Entities:  

Keywords:  3D imaging; colon cancer; laparoscopic surgery

Mesh:

Year:  2018        PMID: 30222527     DOI: 10.1089/lap.2018.0317

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  6 in total

1.  Comparison of short-term surgical outcome between 3D and 2D laparoscopy surgery for gastrointestinal cancer: a systematic review and meta-analysis.

Authors:  Bochao Zhao; Wu Lv; Di Mei; Rui Luo; Shiyang Bao; Baojun Huang; Jie Lin
Journal:  Langenbecks Arch Surg       Date:  2020-01-22       Impact factor: 3.445

2.  Three-dimensional Versus Two-dimensional Laparoscopic Surgery for Colorectal Cancer: Systematic Review and Meta-analysis.

Authors:  George Pantalos; Dimitrios Patsouras; Eleftherios Spartalis; Dimitrios Dimitroulis; Gerasimos Tsourouflis; Nikolaos Nikiteas
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

3.  Robotic or three-dimensional (3D) laparoscopy for right colectomy with complete mesocolic excision (CME) and intracorporeal anastomosis? A propensity score-matching study comparison.

Authors:  Graziano Ceccarelli; Gianluca Costa; Valentina Ferraro; Michele De Rosa; Fabio Rondelli; Walter Bugiantella
Journal:  Surg Endosc       Date:  2020-05-05       Impact factor: 4.584

4.  Single-port 3-dimensional Videoscope-assisted Endoscopic Nipple-sparing Mastectomy in the Management of Breast Cancer.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Chi Wei Mok; Shih-Lung Lin; Chin-Mei Tai; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-08-19

5.  Three-dimensional vs 2-dimensional laparoscopic gastrectomy for gastric cancer: A systematic review and meta-analysis.

Authors:  Lian Chen; Bo Li; Lianli Zeng; Jiani Zhao; Jun Lei; Hongliang Luo; Fengming Yi; Wenxiong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

6.  Three-dimensional versus conventional two-dimensional laparoscopic colectomy for colon cancer: A 3-year follow-up study.

Authors:  Yi-Wen Yang; Sheng-Chieh Huang; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Wei-Shone Chen; Yuan-Tzu Lan; Chun-Chi Lin; Hung-Hsin Lin; Jeng-Kai Jiang
Journal:  J Minim Access Surg       Date:  2022 Apr-Jun       Impact factor: 1.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.